We are live on
!
Find out more
RADX
Radiopharm Theranostics
RADX
RADX
1.65
USD
+0.08
5.1%
At close
Updated
Sep 25, 4:00 PM EDT
Pre-market
After hours
1.67
+0.02
1.21%
1 day
5.1%
5 days
-4.62%
1 month
-33.47%
3 months
-61.89%
6 months
-61.89%
Year to date
-68.02%
1 year
-71.3%
5 years
-90.66%
10 years
-90.66%
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
SCM
1
Stonepine Capital Management
Bend,
Oregon
| $671K | – | – | – |
|
| 2 |
2
HSBC Holdings
London,
United Kingdom
| $254K | +$3.63K | +816 | +1% |
|
| 3 |
RP
3
Regal Partners
Sydney, NSW,
Australia
| $168K | – | – | – |
|
| 4 |
4
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $83.8K | +$17.8K | +4,000 | +25% |
|
| 5 |
5
UBS Group
Zurich,
Switzerland
| $6.31K | -$6.64K | -1,493 | -50% |
|
| 6 |
6
RhumbLine Advisers
Boston,
Massachusetts
| $817 | +$329 | +74 | +61% |
|
| 7 |
SCM
7
Silverarc Capital Management
Boston,
Massachusetts
| – | -$806K | -187,406 | Closed |
|